Scientific session of the Department of Cardiology of Rasoul akram Hospital on effect of the superiority of eplerenone molecule over spironolactone in the treatment of
saypha training workshop was held on september 23, 2022 at Iranian Clinic in Tehran, with the presence of Tehran beauty physicians and dermatologists. Furthermore to
Scientific meeting (advisory board) of Kimiara company regarding the position of Lepronzo (eplerenone 25 and 50) in the treatment of heart failure and hypertension on
Scientific meeting of Kerman’s cardiologists sponsored by Kimiara company Subject: The effects of antiplatelet drugs in the treatment of Acute and Chronic Coronary Syndrome and
Subject: Effect of ticagrelor (its place in coronary syndrome) and the effects of eplerenone (Leprenzo) in the treatment of hypertension and heart failure in clinical
Saypha training workshop with the presence of aesthetic physicians from Tabriz, Urmia and Ardabil was held on 3 December 2021 in Laleh Park Hotel in
Daily Heart Symposium on Chronic Coronary Syndrome, will be held on Friday, September 10, 1400. The program consists of 3 parts. The topics, schedule and
Shahid Madani Tabriz Heart Center morning meeting was held on july 23, 1400 on the role of Ticagrelor. in the treatment of Acute Coronary Syndrome
Holding the scientific program of Tehran Heart Center Cath Conference with lecture of Dr. Rahimi, (Kimiara Company’ Medical Science Liaison), on the role of Ticagloror
Kimiaara Pharmaceutical Company was established in 2005 as one of the subsidiaries of Ahran Tejarat Group.
Address : 2nd Floor, No. 27, Sharifi St., North Gandhi Ave., Tehran, Iran
All rights of this website belong to Kimiaara Pharmaceutical Company. © 2024
